Brief: Aclaris Therapeutics Announces Exclusive, Global License Agreement With Biosion
18/11/2024 13:21
Nov 18 (Reuters) - Aclaris Therapeutics Inc ACRS.O :
* ACLARIS THERAPEUTICS ANNOUNCES EXCLUSIVE, GLOBAL LICENSE
AGREEMENT WITH BIOSION, INC., ADDING POTENTIAL BEST-IN-CLASS
BIOLOGICS ASSETS TO PIPELINE
* ACLARIS THERAPEUTICS INC - ENTERED EXCLUSIVE LICENSE
AGREEMENT
WITH BIOSION FOR WORLDWIDE RIGHTS TO BSI-045B & BSI-502
Source text: ID:nGNX61z9C6
Further company coverage: ACRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aclaris Therapeutics
See all newsAclaris Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
Aclaris Therapeutics Q3 revenue beats analyst estimates
Brief: Aclaris Therapeutics Q3 Net Income USD -18.51 Million Vs. IBES Estimate USD -23.7 Million
Aclaris Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aclaris Therapeutics Q2 revenue beats analyst estimates